Abstract:AIM: To clone and characterize novel genes that might be involved in hepatocellular carcinoma. METHODS: An EST fragment differentially expressed between hepatocellular carcinoma (HCC) and its adjacent nontumorous liver tissues had been doned using suppression subtractive hybridization (SSH). With this approach, we identified a novel EST that consisted of 447bp. In order to gain its full-length cDNA fragment, two gene-specific primers were designed for 3′-rapid amplification of cDNA end RACE. One HCC cell line, HepG2, was maintained in the RPMI1640 media and recommended culture conditions. Total RNA was extracted from HepG2 by the SV Total RNA Isolation System (Promega). PACE reactions were prepared using the SMART™ RACE cDNA amplification kit (Clontech). Initial amplification was carried out with gene-specific primer 3′GSP2(5′-CGCATAGT ACCAGTATCGACAA AGG-3′), followed by nested PCR using gene-specific primer 3′NGSP2(5′-TCCACATTACGGACCCGACGGATT- 3′). These amplified cDNA fragments obtained from RACE were subcloned into the PMD18-T vector (TaKaRa) and sequenced by ABI PRISM377 DNA sequencer. Basic local aligment search tools were carried out using BLASTN and dbEST and nr database. Northern blot was applied to detect the expression of these cDNA fragments between HCC and its adjacent nontumorous liver tissues. A total of 3 liver specimens were collected from the Southwest Hospital of Chongqing in China. The final diagnosis of HCC was confirmed by histological examination. Total RNA was extracted from either HCC or its adjacent nontumorous liver tissues in the same way. These cDNA fragments were excised from the PMD18-T vector, purified and 32P-labeled as cDNA probes using the random primed labeling method. Northern blot was prepared by using the ExpressHyb™ hybridization solution (Clontech) according to the protocol provided by the manufacturer. Combination of Northern blot and virtual Northern (http://www.ncbi.nlm.nih.gov/SAGE) (series analysis of gene expression, SAGE), expression of these cDNA fragments in multiple carcinoma and normal tissues were analyzed. RESULTS: Five EST fragments (694 447-3, 724 447-3, 697 447-3, 711 447-3, 692 447-3) were cloned, including two EST fragments with ploy (A) tail (694 447-3, 724 447-3). Compared with ESTs in GeneBank, the two EST fragments with ploy (A) tail represented novel genes with a common sequence. Five EST fragments accession numbers in Genebank were CK730344, CK730345, CK730346, CK730347, CK730348, respectively. Northern blot revealed that 694 447-3, 724 447-3 presented higher expression in HCC than that in its adjacent nontumorous liver tissues. Virtual Northern blot (SAGE) revealed that 694 447-3, 724 447-3 presented higher expression in multiple cancers that contained in brain, colon, breast, lung and stomach than that in their normal tissues. CONCLUSION: Two novel human hepatocellular carcinoma-associated cDNA fragments are identified. RACE technique is a rapid and effective method for seeking for disease related genes in specific tissues.

Genetic Alterations of Hepatocellular Carcinoma by Random Amplified Polymorphic DNA Analysis and Cloning Sequencing of Tumor Differential DNA Fragment

Genetic Polymorphisms of Xrcc1 Gene and Susceptibility to Hepatocellular Carcinoma in Chinese Population

Rapid cloning and expression of hepatocellular carcinoma associated cDNA fragments

Genomic Instability in Hepatocellular Carcinoma Revealed by Using the Random Amplified Polymorphic DNA Method

Characterization of Genomic Alterations, Tumor Mutational Burden and PDL1 Expression in 181 Chinese Hepatocellular Carcinomas.

Molecular profiling of Chinese patients with advanced hepatocellular carcinoma using circulating tumor DNA.

The Association Between Methylation Patterns of DNAH17 and Clinicopathological Factors in Hepatocellular Carcinoma

Correlation Between Genomic DNA Copy Number Alterations and Transcriptional Expression in Hepatitis B Virus‐associated Hepatocellular Carcinoma

The Genetic Alteration of P16 and CDK4 Genes and Their Relations to HBV Infection in Human Hepatocellular Carcinoma

[Microsatellite Alterations of Circulating DNA in the Plasma of Patients with Hepatocellular Carcinoma].

Abstract A25: Array-based Comparative Genomic Hybridization of Hepatocellular Carcinoma Reveals a Unique Genomic Aberration Pattern in Tumors with Poor Prognosis

Allelic Loss And Gain, But Not Genomic Instability, As The Major Somatic Mutation In Primary Hepatocellular Carcinoma

Genomic profiling informs therapies and prognosis for patients with hepatocellular carcinoma in clinical practice

The potential, analysis and prospect of ctDNA sequencing in hepatocellular carcinoma

Screening of Novel Hepatocellular Carcinoma-Associated Genes

Identification of Candidate Diagnostic Tumor Markers for Human Hepatocellular Carcinoma Using Genechip Technology

[Correlation of C-Myc Gene Amplification, MTS1/p16 Gene Alternation, and HBV Infection in Human Hepatocellular Carcinoma].

Quantification of Plasma Htert DNA in Hepatocellular Carcinoma Patients by Quantitative Fluorescent Polymerase Chain Reaction.

Circulating Tumor Dna Profiling Reveals Clonal Evolution And Real-Time Disease Progression In Advanced Hepatocellular Carcinoma

Application of Plasma Circulating Cell-Free DNA Detection to the Molecular Diagnosis of Hepatocellular Carcinoma.

Complete Genome Sequencing and Clinical Analysis of Intrahepatic Hepatitis B Virus Cccdna from HCC.